Dipeptidyl peptidase 4 inhibition ameliorates hypertension via normalizing preload through the RAAS axis

被引：0
|
作者：
Kawase, H. [1 ]
Bando, Y. Kureishi [1 ]
Aoyama, M. [1 ]
Murohara, T. [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5181
引用
收藏
页码：913 / 913
页数：1
相关论文
共 50 条
  • [21] Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
    Kirby, Mark
    Yu, Denise M. T.
    O'Connor, Stephen P.
    Gorrell, Mark D.
    CLINICAL SCIENCE, 2010, 118 (1-2) : 31 - 41
  • [22] Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes
    Del Prato, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 : 38 - 48
  • [23] Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects
    Takagaki, Yuta
    Koya, Daisuke
    Kanasaki, Keizo
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (01): : 56 - 66
  • [24] The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES CARE, 2014, 37 (10) : 2884 - 2894
  • [25] Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice
    Brown, Scott M.
    Smith, Cassandra E.
    Meuth, Alex I.
    Khan, Maloree
    Aroor, Annayya R.
    Cleeton, Hannah M.
    Meininger, Gerald A.
    Sowers, James R.
    DeMarco, Vincent G.
    Chandrasekar, Bysani
    Nistala, Ravi
    Bender, Shawn B.
    ENDOCRINOLOGY, 2017, 158 (10) : 3592 - 3604
  • [26] Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV
    Po-Kai Huang
    Shian-Ren Lin
    Chia-Hsiang Chang
    May-Jwan Tsai
    Der-Nan Lee
    Ching-Feng Weng
    Scientific Reports, 9
  • [27] Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV
    Huang, Po-Kai
    Lin, Shian-Ren
    Chang, Chia-Hsiang
    Tsai, May-Jwan
    Lee, Der-Nan
    Weng, Ching-Feng
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [28] Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis
    Yang, Fan
    Takagaki, Yuta
    Yoshitomi, Yasuo
    Ikeda, Takayuki
    Li, Jinpeng
    Kitada, Munehiro
    Kumagai, Asako
    Kawakita, Emi
    Shi, Sen
    Kanasaki, Keizo
    Koya, Daisuke
    CANCER RESEARCH, 2019, 79 (04) : 735 - 746
  • [29] Response to Letter to the Editor: "Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin"
    Wilson, Jessica R.
    Shuey, Megan M.
    Brown, Nancy J.
    Devin, Jessica K.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (03)
  • [30] Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
    Solerte, Sebastiano Bruno
    Di Sabatino, Antonio
    Galli, Massimo
    Fiorina, Paolo
    ACTA DIABETOLOGICA, 2020, 57 (07) : 779 - 783
12345